RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL
Volume: 71, Issue: 11, Pages: A289 - A289
Published: Mar 1, 2018
Abstract
The RE-DUAL-PCI trial randomized 2725 percutaneous coronary intervention (PCI) patients with atrial fibrillation (AF) to triple therapy (warfarin, clopidogrel or ticagrelor, and aspirin), or to dabigatran (110 or 150 mg twice daily) dual therapy, with clopidogrel or ticagrelor. Primary...
Paper Details
Title
RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL
Published Date
Mar 1, 2018
Volume
71
Issue
11
Pages
A289 - A289
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History